GANZYK-RTU

PeakSM

ganciclovir

NDAINTRAVENOUSSOLUTION

Approved

Feb 2017

Lifecycle

Peak

Competitive Pressure

0/100

Clinical Trials

Clinical Trials (5)

NCT00002156Phase 2Completed

A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )

194 enrolled

Cytomegalovirus RetinitisHIV Infections

NCT00002330N/ACompleted

A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

280 enrolled

Cytomegalovirus RetinitisHIV Infections

NCT00001100Phase 3Completed

A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.

NCT00001062Phase 1Completed

A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes

NCT00000665N/ACompleted

Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component